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Aging With Heart Failure*
Physiological Assessments
and Risk for Hospital Admission
Philip B. Adamson, MD
Oklahoma City, Oklahoma
Healthcare systems that treat patients with heart failure
have the daunting task of improving outcomes or be faced
with economic penalty. Specifically, the need for readmis-
sion to the hospital after inpatient care and appropriate
application of consensus-recommended medical and device
therapies for heart failure is monitored as a means to
evaluate clinical performance. As a result, there is an
increased focus on the risk for hospital admission in new
clinical studies and prospective trials. Many trials are now
designed with heart failure–related hospital admission as the
primary outcome measure—a shift from mortality or disease
progression. Certainly, heart failure–related hospital admis-
sions have skyrocketed over the past 20 years despite major
breakthroughs in disease-modifying therapies (1). This
single cost center accounts for much of the $30 billion
spent on heart failure by the Centers for Medicare and
Medicaid Services. There is a significant need to develop a
better understanding of strategies that reduce decompensa-
tion and that prevent the need for in-hospital care.
See page 635
The study by Chaudhry et al. (2) in this issue of the
Journal provides novel insight into the risk factors for
hospital admission in a group of older patients with new-
onset heart failure. This is a growing and very important
segment of the U.S. heart failure population that accounts
for a significant number of hospital admissions, as suggested
by prospective registry studies. Why is it important to focus
on this population? The answer to this question becomes
clear when one considers the characteristics of the typical
patient involved in clinical trials that have established
consensus-recommended therapies. Patients in the U.S.
carvedilol trials (3), for example, were younger (mean age:
58 years), had low left ventricular ejection fractions (LVEF)
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months. The first cardiac resynchronization therapy trials
also included younger patients (mean ages: MIRACLE [4],
4 years; COMPANION [5], 68 years) with a low LVEF.
he study by Chaudhry et al. (2) demonstrates that the
ajority of older patients with new-onset heart failure in the
ardiovascular Health Study were nothing like those included
n prospective trials. In fact, most of the subjects in Chaudhry
nd colleagues’ study would not have been eligible for inclusion
n trials establishing consensus-recommended therapies (2).
Subjects in the study by Chaudhry et al. (2) were, by
esign, older (mean age, 79.7 years), and over one-half
56.8%) of the patients had LVEF 45%, comprising a
roup for whom no consensus about treatments exists. The
ain focus of their study was to determine whether physi-
logical assessments not routinely performed in clinical
ractice were useful in predicting the risk for hospital
dmission. They found that 2 measures of physiological
ell-being—weak grip and slow gait—together with de-
ression were significant risk factors for subsequent hospital
dmission (2). Patients in this age bracket are many times
tereotyped as being physically weak with a slower gait, but
his study found that fewer than 25% of the patients had one
f these characteristics. When present, however, these compo-
ents of a patient’s status were associated with as high a risk for
ospital admission as severe symptoms or low LVEF.
The authors suggest that the findings provide a basis for
change in the clinical assessment of older patients with
eart failure. Although this may be true, what should be
one about the presence of a slow gait or weak grip? The
uthors reference results from the HF-ACTION trial (6)
nd suggest that exercise training may be an easy fix for
hese 2 problems. One must remember, though, that the
opulation in HF-ACTION was much younger (median
ge: 59 years) and that the intervention required 36 super-
ised exercise sessions transitioned to home exercise. This
evel of exercise training had no impact on the primary,
omposite endpoint of mortality and all-cause admission,
ven in younger patients. Risk adjustment of the primary
ndpoint, accounting for prognostic factors, led to a modest,
tatistically significant impact. The secondary, composite
ndpoint of mortality and heart failure–related hospital
dmission was modestly changed in the exercise group (after
djustment), even with documented improvement in exer-
ise stamina. Supervised exercise training is expensive and,
t least based on the HF-ACTION data, would not
ignificantly affect the need for hospital admission. What
bout weak grip? Adding resistance training to aerobic
ctivity has been evaluated only in the context of exercise
ndurance in small cohorts (7). No prospective data exist to
redict whether exercises that focus on improving upper
xtremity strength would change outcomes in heart failure
atients. Finally, although it is clear that severe depressive
ymptoms are associated with poorer outcomes, no consen-
us exists about the effects of treatment (8).
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Assessing Older Heart Failure Patients February 12, 2013:643–4It is always tempting to assume that interventions designed
to change risk factors may change outcomes. An observed
association is hypothesis generating, and Chaudhry et al.
should be congratulated for focusing on physiological evalua-
tions in older patients with heart failure. These observations are
expected to lead to prospective clinical evaluation of interven-
tions that target these risk factors, possibly leading to a
decreased need for hospital admission. Should physicians test
for impairments in muscle strength, gait speed, psychological
status in older patients with new-onset heart failure? It seems
reasonable to suggest this type of assessment in all patients with
new-onset heart failure who are clinically stable. At this time,
however, response to slow gait or weak grip is limited to risk
stratification, which may lead to closer clinical monitoring of
weaker patients. Hopefully, future prospective clinical trial
results will provide clearer direction.
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